Discussing psychedelic therapies and the PsyPal project on EFNA’s Brain Health Matters podcast
PAREA Founder and Executive Director, Tadeusz Hawrot, recently joined the Brain Health Matters podcast, hosted by the European Federation of Neurological Associations (EFNA), to discuss the topic of psychedelic therapies with the neurology community. Focusing on the episode’s theme of patient involvement in neuroscience research, a central topic of the conversation was the PsyPal project.
The EU-funded project, in which both PAREA and EFNA are involved, will explore the potential of psilocybin therapy to treat psychological distress in chronic, incurable conditions, including three neurological conditions. PsyPal embraces the principles of public and patient involvement (PPI) and meaningful patient engagement to ensure that the research reflects the needs and preferences of the people who may benefit from these treatments. By directly involving medical and patient communities, the project is committed to maintaining a patient-centred approach and the highest ethical standards at every stage.
